Modulation of Oxidative Stress by Twist Oncoproteins

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Floc'h, Nicolas ^a,b,f   Kolodziejski, Jakub ^a,b   Akkari, Leila ^a,b,g   Simonin, Yannick ^a,b   Ansieau, Stéphane ^a,c,d   Puisieux, Alain ^a,c,d,e   Hibner, Urszula ^a,b   Lassus, Patrice ^a,b  

^a CNRS   (France)

^b UNIV MONTPELLIER   (France)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d UNIVERSITÉ DE LYON   (France)

^e CENTRE LÉON BÉRARD   (France)

^f Columbia University College of Physicians and Surgeons ^*  (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; ONCOPROTEIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; TRANSCRIPTION FACTOR TWIST2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL AGING; CELL CULTURE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLEIOTROPY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANTIOXIDANTS; APOPTOSIS; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; NUCLEAR PROTEINS; ONCOGENE PROTEINS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-MYC; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; TWIST TRANSCRIPTION FACTOR;

EID: 84881492947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072490     Document Type: Article

References (37)

1. Barnes RM, Firulli AB, (2009) A twist of insight- the role of Twist-family bHLH factors in development. The International journal of developmental biology 53: 909-924.
2. Leptin M, (1991) twist and snail as positive and negative regulators during Drosophila mesoderm development. Genes & development 5: 1568-1576.
3. Chen ZF, Behringer RR, (1995) twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & development 9: 686-699.
4. Sosic D, Richardson JA, Yu K, Ornitz DM, Olson EN, (2003) Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 112: 169-180.
5. Isenmann S, Arthur A, Zannettino AC, Turner JL, Shi S, et al. (2009) TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem cells 27: 2457-2468.
6. Sharabi AB, Aldrich M, Sosic D, Olson EN, Friedman AD, et al. (2008) Twist-2 controls myeloid lineage development and function. PLoS biology 6: e316.
7. Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A, (2010) TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29: 3173-3184.
8. Puisieux A, Valsesia-Wittmann S, Ansieau S, (2006) A twist for survival and cancer progression. British journal of cancer 94: 13-17.
9. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
10. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PloS one 3: e2888.
11. Vesuna F, Lisok A, Kimble B, Raman V, (2009) Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11: 1318-1328.
12. Yang J, Mani SA, Weinberg RA, (2006) Exploring a new twist on tumor metastasis. Cancer research 66: 4549-4552.
13. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, et al. (2008) Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer cell 14: 79-89.
14. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, et al. (1999) Twist is a potential oncogene that inhibits apoptosis. Genes & development 13: 2207-2217.
15. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, et al. (2004) Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer cell 6: 625-630.
16. Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, et al. (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer research 65: 5153-5162.
17. Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, et al. (2007) Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Molecular and cellular biology 27: 3920-3935.
18. Veal EA, Day AM, Morgan BA, (2007) Hydrogen peroxide sensing and signaling. Molecular cell 26: 1-14.
19. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. The international journal of biochemistry & cell biology 39: 44-84.
20. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, et al. (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer cell 14: 458-470.
21. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, et al. (2002) E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Molecular cell 9: 1017-1029.
22. Sagun KC, Carcamo JM, Golde DW, (2006) Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-MYC. Mutation research 593: 64-79.
23. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, et al. (2002) c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Molecular cell 9: 1031-1044.
24. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, et al. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
25. Ledenev AN, Konstantinov AA, Popova E, Ruuge EK, (1986) A simple assay of the superoxide generation rate with Tiron as an EPR-visible radical scavenger. Biochemistry international 13: 391-396.
26. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, et al. (2002) E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9: 1017-1029.
27. Aruoma OI, Halliwell B, Hoey BM, Butler J, (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors. The Biochemical journal 256: 251-255.
28. Jakobsson PJ, Mancini JA, Riendeau D, Ford-Hutchinson AW, (1997) Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities. The Journal of biological chemistry 272: 22934-22939.
29. Muffat J, Walker DW, Benzer S, (2008) Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proceedings of the National Academy of Sciences of the United States of America 105: 7088-7093.
30. Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, et al. (2008) 3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 149: 3267-3273.
31. Neumeier M, Weigert J, Schaffler A, Weiss TS, Schmidl C, et al. (2006) Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro. Biochemical and biophysical research communications 350: 731-735.
32. Hu J, Yao H, Gan F, Tokarski A, Wang Y, (2012) Interaction of OKL38 and p53 in regulating mitochondrial structure and function. PloS one 7: e43362.
33. Martin-Montalvo A, Villalba JM, Navas P, de Cabo R, (2011) NRF2, cancer and calorie restriction. Oncogene 30: 505-520.
34. Trachootham D, Alexandre J, Huang P, (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature reviews Drug discovery 8: 579-591.
35. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, et al. (2013) Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer cell 23: 316-331.
36. Charrier-Savournin FB, Chateau MT, Gire V, Sedivy J, Piette J, et al. (2004) p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Molecular biology of the cell 15: 3965-3976.
37. Akkari L, Haouzi D, Biname F, Floc'h N, Lassus P, et al. (2010) Cell shape and TGF-beta signaling define the choice of lineage during in vitro differentiation of mouse primary hepatic precursors. Journal of cellular physiology 225: 186-195.